| scholarly article | Q13442814 |
| P2093 | author name string | C Khanna | |
| C A London | |||
| C Mazcko | |||
| J K McCleese | |||
| M D Bear | |||
| S K Kulp | |||
| P2860 | cites work | Cross-talk between the proto-oncogenes Met and Ron | Q22254408 |
| EGFR/Met association regulates EGFR TKI resistance in breast cancer | Q24338635 | ||
| MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib | Q24646295 | ||
| MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling | Q27851406 | ||
| The RON and MET oncogenes are co-expressed in human ovarian carcinomas and cooperate in activating invasiveness | Q28201215 | ||
| A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family | Q28285975 | ||
| Intermolecular association of the p185neu protein and EGF receptor modulates EGF receptor function | Q28678683 | ||
| Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors | Q29547463 | ||
| Met and c-Src cooperate to compensate for loss of epidermal growth factor receptor kinase activity in breast cancer cells | Q30415408 | ||
| Transcription-dependent epidermal growth factor receptor activation by hepatocyte growth factor | Q30436756 | ||
| Gefitinib: a review of its use in the management of advanced non-small-cell lung cancer | Q33207883 | ||
| Met-related receptor tyrosine kinase Ron in tumor growth and metastasis. | Q33916081 | ||
| The type III epidermal growth factor receptor mutation. Biological significance and potential target for anti-cancer therapy | Q34325749 | ||
| A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor. | Q34398347 | ||
| From concept to reality: the long road to c-Met and RON receptor tyrosine kinase inhibitors for the treatment of cancer | Q34939284 | ||
| HGF-independent potentiation of EGFR action by c-Met | Q35078530 | ||
| Update on the biology and management of canine osteosarcoma | Q35173803 | ||
| Mitogen-activated protein kinases in apoptosis regulation | Q35743118 | ||
| Epidermal growth factor receptor plays a significant role in hepatocyte growth factor mediated biological responses in mammary epithelial cells | Q36090650 | ||
| RON, a tyrosine kinase receptor involved in tumor progression and metastasis | Q36096934 | ||
| Small molecules with EGFR-TK inhibitor activity | Q36108991 | ||
| Signaling networks assembled by oncogenic EGFR and c-Met | Q36392991 | ||
| Cross talk between c-Met and epidermal growth factor receptor during retinal pigment epithelial wound healing | Q36407762 | ||
| Copy number gains in EGFR and copy number losses in PTEN are common events in osteosarcoma tumors | Q36486421 | ||
| Evaluation of gefitinib for treatment of refractory solid tumors and central nervous system malignancies in pediatric patients | Q36523502 | ||
| Constitutive activation of the RON gene promotes invasive growth but not transformation | Q36564393 | ||
| Co-expression of RON and MET is a prognostic indicator for patients with transitional-cell carcinoma of the bladder | Q36615866 | ||
| Comparative biology of human and canine osteosarcoma. | Q36757513 | ||
| Dual MET-EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer. | Q36882696 | ||
| Crosstalk in Met receptor oncogenesis | Q37598460 | ||
| Blocking of ERK1 and ERK2 sensitizes human mesothelioma cells to doxorubicin | Q39620039 | ||
| met oncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre-clinical model of human osteosarcoma. | Q39859049 | ||
| Met receptor contributes to trastuzumab resistance of Her2-overexpressing breast cancer cells | Q40006240 | ||
| Epidermal growth factor receptor in osteosarcoma: expression and mutational analysis | Q40131620 | ||
| A novel small molecule Met inhibitor, PF2362376, exhibits biological activity against osteosarcoma. | Q40179159 | ||
| Prognostic significance of co-expression of RON and MET receptors in node-negative breast cancer patients. | Q40443024 | ||
| Cross-talk between epidermal growth factor receptor and c-Met signal pathways in transformed cells | Q40893206 | ||
| The HGF receptor family: unconventional signal transducers for invasive cell growth | Q41458148 | ||
| Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer | Q41969702 | ||
| Acquired resistance of non-small cell lung cancer cells to MET kinase inhibition is mediated by a switch to epidermal growth factor receptor dependency | Q42081770 | ||
| Interaction between heterologous receptor tyrosine kinases. Hormone-stimulated insulin receptors activate unoccupied IGF-I receptors. | Q42825078 | ||
| Synthetic lethality screens reveal RPS6 and MST1R as modifiers of insulin-like growth factor-1 receptor inhibitor activity in childhood sarcomas | Q42854019 | ||
| The role of ERK 1/2 and p38 MAP-kinase pathways in taxol-induced apoptosis in human ovarian carcinoma cells | Q43680631 | ||
| A randomized controlled trial of octreotide pamoate long-acting release and carboplatin versus carboplatin alone in dogs with naturally occurring osteosarcoma: evaluation of insulin-like growth factor suppression and chemotherapy. | Q44061944 | ||
| Switching signals on or off by receptor dimerization | Q46100759 | ||
| The prognostic significance of RON and MET receptor coexpression in patients with colorectal cancer | Q46553705 | ||
| Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma | Q47834432 | ||
| The expression of epidermal growth factor receptor and its downstream signaling molecules in osteosarcoma. | Q51825091 | ||
| Platelet-derived growth factor (PDGF) stimulates PDGF receptor subunit dimerization and intersubunit trans-phosphorylation | Q67689119 | ||
| Co-expression and regulation of Met and Ron proto-oncogenes in human hepatocellular carcinoma tissues and cell lines | Q73491986 | ||
| Epidermal growth factor receptor signaling activates met in human anaplastic thyroid carcinoma cells | Q74172362 | ||
| STEALTH liposome-encapsulated cisplatin (SPI-77) versus carboplatin as adjuvant therapy for spontaneously arising osteosarcoma (OSA) in the dog: a randomized multicenter clinical trial | Q74599244 | ||
| The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas | Q77386062 | ||
| Epidermal growth factor receptor expression in high-grade osteosarcomas is associated with a good clinical outcome | Q80341321 | ||
| Tyrosine kinases as targets for cancer therapy | Q80367757 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 2 | |
| P304 | page(s) | 124-139 | |
| P577 | publication date | 2011-12-08 | |
| P1433 | published in | Veterinary and Comparative Oncology | Q15759976 |
| P1476 | title | Met interacts with EGFR and Ron in canine osteosarcoma | |
| P478 | volume | 11 |
| Q95840408 | AKT and JUN are differentially activated in mesenchymal stem cells after infection with human and canine oncolytic adenoviruses |
| Q92190792 | Aberrant RON and MET Co-overexpression as Novel Prognostic Biomarkers of Shortened Patient Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Pancreatic Cancer |
| Q38220804 | Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology |
| Q49602648 | Canine sarcomas as a surrogate for the human disease. |
| Q34768509 | Comparative analysis of the surface exposed proteome of two canine osteosarcoma cell lines and normal canine osteoblasts |
| Q28607304 | Comparative oncology: what dogs and other species can teach us about humans with cancer |
| Q42634367 | Comparative review of human and canine osteosarcoma: morphology, epidemiology, prognosis, treatment and genetics. |
| Q41901776 | Dasatinib Modulates Invasive and Migratory Properties of Canine Osteosarcoma and has Therapeutic Potential in Affected Dogs |
| Q36034972 | Effects of epidermal growth factor receptor kinase inhibition on radiation response in canine osteosarcoma cells |
| Q28084034 | Epidermal growth factor signaling in transformed cells |
| Q28593437 | Hepatocyte growth factor-like protein is a positive regulator of early mammary gland ductal morphogenesis |
| Q42837140 | Inhibitors of HGFA, Matriptase, and Hepsin Serine Proteases: A Nonkinase Strategy to Block Cell Signaling in Cancer |
| Q27313336 | OFD1 and flotillins are integral components of a ciliary signaling protein complex organized by polycystins in renal epithelia and odontoblasts |
| Q92565594 | Ursolic acid suppresses the biological function of osteosarcoma cells |
| Q89170829 | miR-182 regulates trastuzumab resistance by targeting MET in breast cancer cells |
Search more.